Rituximab cancer drug

Numéro d’image : 11854822
Rituximab cancer drug
Rituximab cancer drug. Bottle containing a liquid concentrate of the cancer drug rituximab,which is marketed as MabThera. Rituximab is a monoclonal antibody used to treat B cell non-Hodgkin's lymphoma and B cell leukaemia. B cells are a type of white blood cell. The antibody works by binding to CD20 receptors on the surface of the B cells,which flags them for destruction by the body's immune system. This clears the B cells,including the cancerous cells,from the blood,allowing them to be replaced with healthy cells produced by stem cells in the bone marrow. Rituximab may also be used to treat autoimmune diseases that result from the proliferation of B cells,to help prevent rejection of transplanted organs,and to treat rheumatoid arthritis
Licence : Droits gérés
Crédit: Science Photo Library / Marazzi, Dr. P.
Taille de l’image : 3276 px × 5047 px
Model Release : Non requis
Property Release : Non requis
Restrictions :
  • Editorial use only

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;